Browse All

Current Filters

CLEAR FILTER x

TITLE

Apparent Diffusion Coefficients Show Good Reproducibility But Heterogeneous Change in Response to Treatment with Combrestation A4 Phosphate (CA4P) and Bevacizumab in Patients with Solid Abdominal and Pelvic Tumours

DCE-MRI Demonstration of Antivascular Effects of Combretastatin A4 Phosphate (CA4P) Given in Combination with Bevacizumab to Human Subjects with Advanced Solid Tumours

Methodological Improvements in Multi-Centre Phase I DCE-MRI Studies of Novel Antivascular Drug Treatments: Implications for Reproducibility and Quality Assurance